Parabilis Medicines Patents – Insights & Stats (Updated 2026)

Parabilis Medicines has a total of 108 patents globally, out of which 3 have been granted. Of these 108 patents, 65% patents are active. Europe (EPO) and the United States of America is where Parabilis Medicines has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Parabilis Medicines.

Parabilis Medicines was founded in 2016. Parabilis Medicines is a biotechnology company developing new treatments for serious diseases by targeting specific protein interactions in the body. Its proprietary Helicon technology creates specialized peptide drugs that can precisely bind to disease-related proteins.

The company’s lead drug candidate, zolucatetide, is being developed to block the Wnt/β-catenin signaling pathway, which plays a key role in the growth of several cancers. By targeting this pathway, zolucatetide aims to slow or stop cancer cell growth.

Parabilis Medicines has been expanding its pipeline and strengthening its intellectual property portfolio, positioning itself among the upcoming U.S. IPO candidates that investors are closely monitoring.

Do read about some of the most popular patents of Parabilis Medicines which have been covered by us in this article and also you can find Parabilis Medicines patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Parabilis Medicines patent portfolio.

How many patents does Parabilis Medicines have?

Parabilis Medicines has a total of 108 patents globally. These patents belong to 13 unique patent families. Out of 108 patents, 71 patents are active.

How Many Patents did Parabilis Medicines File Every Year?

Parabilis Medicines Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantParabilis Medicines Applications FiledParabilis Medicines Patents Granted
20262
202541
202411
2023151
202213
2021291
202010
201912
201812

How many Parabilis Medicines patents are Alive/Dead?

Worldwide Patents

Parabilis Medicines Patent Portfolio

How Many Patents did Parabilis Medicines File in Different Countries?

Parabilis Medicines Worldwide Patent Filing

Countries in which Parabilis Medicines Filed Patents

CountryPatents
Europe (EPO)10
United States of America10
Japan8
China8
Canada8
Singapore7
Australia6
India6
Korea (South)5
Israel5
Mexico5
Hong Kong (S.A.R.)5
South Africa4
Eurasia4
Brazil4
New Zealand2

Where are Research Centers of Parabilis Medicines Patents Located?

The Research Centers of Parabilis Medicines Patents is the United States of America.

10 Best Parabilis Medicines Patents

WO2022261257A1 is the most popular patent in the Parabilis Medicines portfolio. It has received 11 citations.

Below is the list of 10 most cited patents of Parabilis Medicines:

Publication NumberCitation Count
WO2022261257A111
WO2022020651A15
US11198713B24
WO2021188659A13
US20230046728A12
WO2021119537A12
WO2020041270A92
US20240376151A11
WO2024130217A11
WO2024130218A11

What Percentage of Parabilis Medicines US Patent Applications were Granted?

Parabilis Medicines (Excluding its subsidiaries) has filed 44 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 31 have been granted leading to a grant rate of 93.94%.

Below are the key stats of Parabilis Medicines patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Parabilis Medicines?

Law FirmTotal ApplicationsSuccess Rate
Smith Gambrell & Russell Llp25100.00%
Novick Kim & Lee Pllc1433.33%
Suzannah K Sundby3100.00%
David And Raymond Patent Firm1100.00%
Ka Filing Llc1100.00%

What are Parabilis Medicines key innovation segments?

What Technologies are Covered by Parabilis Medicines?

The chart below distributes patents filed by Parabilis Medicines in different countries on the basis of the technology protected in patents. It also represents the markets where Parabilis Medicines thinks it’s important to protect particular technological inventions.

R&D Focus: How has Parabilis Medicines search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Parabilis Medicines?

Related Articles

Was this article helpful?

Have a custom data request?

Our Experts Are Here To Help.